Rob Schuurman mainly investigates Virology, Drug resistance, Virus, Viral load and Immunology. The concepts of his Virology study are interwoven with issues in RNA, Reverse transcriptase and Polymerase chain reaction. His work in Drug resistance covers topics such as Pharmacology which are related to areas like Cohort study.
The various areas that he examines in his Virus study include Multiplex, Combination therapy and Microbiology. His work deals with themes such as Cross-sectional study, Sida, Acquired immunodeficiency syndrome, Resistance mutation and Pediatrics, which intersect with Viral load. His work focuses on many connections between Immunology and other disciplines, such as Epidemiology, that overlap with his field of interest in Transmission, Common cold and Respiratory tract.
His primary scientific interests are in Virology, Immunology, Viral load, Drug resistance and Virus. The Virology study combines topics in areas such as RNA, Reverse transcriptase and Polymerase chain reaction. His Immunology study combines topics in areas such as Acquired immunodeficiency syndrome, Stem cell and Transplantation.
His research in Viral load intersects with topics in Surgery, Cross-sectional study, Reverse-transcriptase inhibitor, Human cytomegalovirus and Dried blood spot. His research in Drug resistance focuses on subjects like Internal medicine, which are connected to Oncology and Gastroenterology. His Virus research includes elements of Real-time polymerase chain reaction and Microbiology.
Virology, Internal medicine, Drug resistance, Virus and Viral load are his primary areas of study. Rob Schuurman has researched Virology in several fields, including Nucleic acid amplification technique, RNA, Molecular biology, Molecular diagnostics and Genotype. His studies in Internal medicine integrate themes in fields like HIV drug resistance and Antigen.
The concepts of his Drug resistance study are interwoven with issues in Mutation, Pyrosequencing, Drug levels and Dolutegravir. His studies in Virus integrate themes in fields like Hematopoietic stem cell transplantation, Nucleic acid and DNA. Viral load is a subfield of Immunology that Rob Schuurman studies.
Rob Schuurman spends much of his time researching Virology, Internal medicine, Viral load, Drug resistance and Virus. His Virology research includes themes of Nucleic acid amplification technique, T cell, Immunology, Neisseria gonorrhoeae and Ceftriaxone. His work deals with themes such as Endemic area and Antigen, which intersect with Internal medicine.
His biological study spans a wide range of topics, including Odds ratio, Nested case-control study, HIV drug resistance and Regimen. His Drug resistance study integrates concerns from other disciplines, such as Somatic hypermutation, Cytidine deamination, Mutation, Pyrosequencing and Gastroenterology. Rob Schuurman has included themes like Cochrane Library, Confidence interval, Molecular diagnostics and Respiratory system in his Virus study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Simultaneous Detection of Influenza Viruses A and B Using Real-Time Quantitative PCR
L. J. R. van Elden;M. Nijhuis;P. Schipper;R. Schuurman.
Journal of Clinical Microbiology (2001)
Rapid Changes in Human Immunodeficiency Virus Type 1 RNA Load and Appearance of Drug-Resistant Virus Populations in Persons Treated with Lamivudine (3TC)
Rob Schuurman;Monique Nijhuis;Remko van Leeuwen;Pauline Schipper.
The Journal of Infectious Diseases (1995)
Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management
Annemarie M. J. Wensing;David A. van de Vijver;Gioacchino Angarano;Birgitta Åsjö.
The Journal of Infectious Diseases (2005)
Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy.
Monique Nijhuis;Rob Schuurman;Dorien de Jong;John Erickson.
High-level resistance to (-) enantiomeric 2'-deoxy-3'-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase.
C. A. B. Boucher;N. Cammack;P. Schipper;R. Schuurman.
Antimicrobial Agents and Chemotherapy (1993)
IL-10 Is an Important Mediator of the Enhanced Susceptibility to Pneumococcal Pneumonia after Influenza Infection
Koenraad F. van der Sluijs;Leontine J. R. van Elden;Monique Nijhuis;Rob Schuurman.
Journal of Immunology (2004)
Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review
Roos E Barth;Maarten F Schim van der Loeff;Rob Schuurman;Andy I M Hoepelman.
Lancet Infectious Diseases (2010)
HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study
Raph L Hamers;Carole L Wallis;Cissy Kityo;Margaret Siwale.
Lancet Infectious Diseases (2011)
Transmission of Drug-Resistant HIV-1 Is Stabilizing in Europe
Jurgen Vercauteren;Annemarie M. J. Wensing;David A. M. C. van de Vijver;Jan Albert.
The Journal of Infectious Diseases (2009)
Worldwide evaluation of DNA sequencing approaches for identification of drug resistance mutations in the human immunodeficiency virus type 1 reverse transcriptase.
Rob Schuurman;Lisa Demeter;Patricia Reichelderfer;Jolanda Tijnagel.
Journal of Clinical Microbiology (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: